Human IL-6 High Sensitivity ELISA

Description: This High Sensitivity ELISAs enables the analysis of Interleukin 6 in low concentrations from serum, plasma, or cell culture samples.

eBioscience High Sensitivity ELISA Kits offer accurate quantification below conventional ELISA limits. This is made possible by ther inherent design by amplifying the signal generated by the enzyme horseradish peroxidase (HRP) and the colorimetric-detectable substrate tetramethylbenzidin (TMB) based on Tyramide Signal Amplification (TSA) technology*.

Interleukin-6 (IL-6) is a multi-functional cytokine that regulates immune responses, acute phase reactions and hematopoiesis and may play a central role in host defense mechanisms. IL-6 is usually not produced constitutively by normal cells, but its expression is readily induced by a variety of cytokines,lipopolysaccharide (LPS) or viral infections. IL-6 is a pleiotropic cytokine produced by a variety of cells. It acts on a wide range of tissues, exerting growth-induction, growth-inhibition, and differentiation respectively, depending on the nature of the target cells.

*High Sensitivity ELISAs are based on a patent from PerkinElmer LAS, patent number 5,731,158; 5,583,001; 5,196,306.

Citations: Boucharaba,Ahmed; Serre,Claire Marie; Guglielmi,Julien; Bordet,Jean Claude; Clezardin,Philippe; Peyruchaud,Olivier. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. Proceedings of the National Academy of Sciences U.S.A. 2006;103:9643-9648. (Link)

Z”ller,Nadja Nicole; Kippenberger,Stefan; Tha‡i,Diamant; Mewes,Karsten; Spiegel,Martina; S„ttler,Andrea; Schultz,Maike; Bereiter-Hahn,Jrgen; Kaufmann,Roland; Bernd,August. Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model. Toxicology in Vitro 2008;22:747-759. (Link)

Creely,Steven James; McTernan,Philip Gerard; Kusminski,Christine Maria; Fisher,ffolliot Martin; Khanolkar,Manish; Evans,Mark; Harte,Alison louise; Kumar,Sudhesh. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Endocrinology and Metabolism 2006;292:00302(Link)

Piconi,L.; Quagliaro,L.; Da Ros,R.; Assaloni,R.; Giugliano,D.; Esposito,K.; Szabo,C.; Ceriello,A.. Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. Journal of Thrombosis and Haemostasis 2004;2:1453-1459. (Link)

Kohler,M.; Ayers,L.; Pepperell,J.C.T.; Packwood,K.L.; Ferry,B.; Crosthwaite,N.; Craig,S.; Siccoli,M.M.; Davies,R.J.O.; Stradling,J.R.. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 2009;64:67-73. (Link)

Weigand,Markus A.; Schmidt,Heinfried; Zhao,Qingyu; Plaschke,Konstanze; Martin,Eike; Bardenheuer,Hubert J.. Ketamine Modulates the Stimulated Adhesion Molecule Expression on Human Neutrophils In Vitro. Anesthesia & Analgesia 2000;90:206(Link)

Gruber,H.J.; Mayer,C.; Mangge,H.; Fauler,G.; Grandits,N.; Wilders-Truschnig,M.. Obesity reduces the bioavailability of nitric oxide in juveniles. Int.J.Obes.(Lond) 2008;32:826-831. (Link)

Gitto,E.; Romeo,C.; Reiter,R.J.; Impellizzeri,P.; Pesce,S.; Basile,M.; Antonuccio,P.; Trimarchi,G.; Gentile,C.; Barberi,I.. Melatonin reduces oxidative stress in surgical neonates. Journal of Pediatric Surgery 2004;39:184-189. (Link)

Xiao,Jing; Leung,Joseph C.K.; Chan,Loretta Y.Y.; Guo,Hong; Lai,Kar Neng. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy. Nephrology Dialysis Transplantation 2009;(Link)

Karth,Georg Delle; Buberl,Anton; Nikfardjam,Mariam; Meyer,Brigitte; Wollenek,Gregor; Grimm,Michael; Lassnigg,Andrea; Brannath,Werner; Hiesmayr,Michael; Heinz,Gottfried. Role of amiodarone on the systemic inflammatory response induced by cardiac surgery: proinflammatory actions: [Role de l'amiodarone sur la reaction inflammatoire systemique provoquee par la chirurgie cardiaque : actions pro-inflammatoires]. Canadian Journal of Anesthesia 2007;54:262-268. (Link)

Setola,Emanuela; Losa,Marco; Lanzi,Roberto; Lucotti,Pietro; Monti,Lucilla D.; Castrignano,Tristana; Galluccio,Elena; Giovanelli,Massimo; Piatti,PierMarco. Increased insulin-stimulated endothelin-1 release is a distinct vascular phenotype distinguishing Cushing's disease from metabolic syndrome. Clinical Endocrinology 2007;66:586-592. (Link)

Stefanska,Anna; Sypniewskay,Grazyna; Senterkiewicz,Lilla. Inflammatory Markers and Cardiovascular Risk in Healthy Polish Women across the Menopausal Transition. Clinical Chemistry 2005;51:1893-1895. (Link)

Ballinger,A.B.; Woolley,J.A.; Ahmed,M.; Mulcahy,H.; Alstead,E.M.; Landon,J.; Clark,M.L.; Farthing,M.J.G.. Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction. Gut 1998;42:555-559. (Link)

Lam,Man Fai; Leung,Joseph C.K.; Lo,Wai Kei; Tam,Sidney; Chong,Mei ching; Lui,Sing Leung; Tse,Kai Chung; Chan,Tak Mao; Lai,Kar Neng. Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis. Nephrology Dialysis Transplantation 2007;22:1445-1450. (Link)

Lai,Kar Neng; Leung,Joseph C.K.; Chan,Loretta Y.Y.; Saleem,Moin A.; Mathieson,Peter W.; Lai,Fernand M.; Tang,Sydney C.W.. Activation of podocytes by mesangial-derived TNF-{alpha}: glomerulo-podocytic communication in IgA nephropathy. Renal Physiology 2008;294:F945-F955. (Link)

Genesca,Joan; Segura,Rosa; Gonzalez,Antonio; Catalan,Robert; Marti,Ramon; Torregrosa,Mireia; Cereto,Ferran; Martinez,Moises; Esteban,Rafael; Guardia,Jaime. Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients. The American Journal of Gastroenterology 2000;95:1539-1544. (Link)

Afshari,J.Tavakkol; Ghomian,N.; Shameli,A.; Shakeri,M.T.; Fahmidehkar,M.A.; Mahajer,E.; Khoshnavaz,R.; Emadzadeh,M.. Determination of Interleukin-6 and Tumor Necrosis Factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia. BMC Pregnancy and Childbirth 2005;5:14(Link)

Cao,Huibi; Wang,Anan; Martin,Bernard; Koehler,David; Zeitlin,Pamela; Tanawell,A.; Hu,Jim. Down-regulation of IL-8 expression in human airway epithelial cells through helper-dependent adenoviral-mediated RNA interference. Cell Res 2005;15:111-119. (Link)

Vazquez-Agell,Monica; Sacanella,Emilio; Tobias,Ester; Monagas,Maria; Antunez,Emilia; Zamora-Ros,Raul; Andres-Lacueva,Cristina; Lamuela-Raventos,Rosa Ma; Fernandez-Sola,Joaquim; Nicolas,Jose Ma; Estruch,Ramon. Inflammatory Markers of Atherosclerosis Are Decreased after Moderate Consumption of Cava (Sparkling Wine) in Men with Low Cardiovascular Risk. The Journal of Nutrition 2007;137:2279-2284. (Link)

Schonbeck,Uwe; Gerdes,Norbert; Varo,Nerea; Reynolds,Rebecca S.; Horton,Daniel B.; Bavendiek,Udo; Robbie,Linda; Ganz,Peter; Kinlay,Scott; Libby,Peter. Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular Cells. Circulation 2002;106:2888-2893. (Link)

Targher,Giovanni; Zenari,Luciano; Bertolini,Lorenzo; Muggeo,Michele; Zoppini,Giacomo. Elevated Levels of Interleukin-6 in Young Adults With Type 1 Diabetes Without Clinical Evidence of Microvascular and Macrovascular Complications. Diabetes Care 2001;24:956-957. (Link)

Chan,Wai Long; Leung,Joseph; Chan,Loretta; Tam,K.; Tang,Sydney; Lai,Kar Neng. BMP-7 protects mesangial cells from injury by polymeric IgA. Kidney Int 2008;74:1026-1039. (Link)

Mazzei,Valerio; Nasso,Giuseppe; Salamone,Giovanni; Castorino,Filippo; Tommasini,Antonello; Anselmi,Amedeo. Prospective Randomized Comparison of Coronary Bypass Grafting With Minimal Extracorporeal Circulation System (MECC) Versus Off-Pump Coronary Surgery. Circulation 2007;116:1761-1767. (Link)

Fiane,Arnt E.; Videm,Vibeke; Lingaas,Per S.; Heggelund,Lars; Nielsen,Erik W.; Geiran,Odd R.; Fung,Michael; Mollnes,Tom E.. Mechanism of Complement Activation and Its Role in the Inflammatory Response After Thoracoabdominal Aortic Aneurysm Repair. Circulation 2003;108:849-856. (Link)

Maczynska,Iwona; Millo,Barbara; Ratajczak-StefaDska,Violetta; Maleszka,Romuald; Szych,Zbigniew; Kurpisz,Maciej; Giedrys-Kalemba,Stefania. Proinflammatory cytokine (IL-1beta, IL-6, IL-12, IL-18 and TNF-alpha) levels in sera of patients with subacute cutaneous lupus erythematosus (SCLE). Immunology letters 2006;102:79-82. (Link)

References: Helfgott,D.C.; Tatter,S.B.; Santhanam,U.; Clarick,R.H.; Bhardwaj,N.; May,L.T.; Sehgal,P.B.. Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J.Immunol. 1989;142:948-953. (Link)

Ueyama,M.; Maruyama,I.; Osame,M.; Sawada,Y.. Marked increase in plasma interleukin-6 in burn patients. J.Lab Clin.Med. 1992;120:693-698. (Link)

May,L.T.; Santhanam,U.; Tatter,S.B.; Bhardwaj,N.; Ghrayeb,J.; Sehgal,P.B.. Phosphorylation of secreted forms of human beta 2-interferon/hepatocyte stimulating factor/interleukin-6. Biochem.Biophys.Res.Commun. 1988;152:1144-1150. (Link)

Martinez-Maza,O.. IL6 and AIDS. Res.Immunol. 1992;143:764-769. (Link)

Santhanam,U.; Avila,C.; Romero,R.; Viguet,H.; Ida,N.; Sakurai,S.; Sehgal,P.B.. Cytokines in normal and abnormal parturition: elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection. Cytokine 1991;3:155-163. (Link)

Nakajima,K.; Martinez-Maza,O.; Hirano,T.; Breen,E.C.; Nishanian,P.G.; Salazar-Gonzalez,J.F.; Fahey,J.L.; Kishimoto,T.. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J.Immunol. 1989;142:531-536. (Link)

Cayphas,S.; Van,Damme J.; Vink,A.; Simpson,R.J.; Billiau,A.; Van,Snick J.. Identification of an interleukin HP1-like plasmacytoma growth factor produced by L cells in response to viral infection. J.Immunol. 1987;139:2965-2969. (Link)

Koj Aleksander. Regulation of the acute phase and immune responses: interleukin-6. Ann.N Y.Acad.Sci. 1989;557:1-583. (Link)

Hirano,T.; Matsuda,T.; Turner,M.; Miyasaka,N.; Buchan,G.; Tang,B.; Sato,K.; Shimizu,M.; Maini,R.; Feldmann,M.; .. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur.J.Immunol. 1988;18:1797-1801. (Link)

Sheron,N.; Bird,G.; Goka,J.; Alexander,G.; Williams,R.. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin.Exp.Immunol. 1991;84:449-453. (Link)

Zilberstein,A.; Ruggieri,R.; Korn,J.H.; Revel,M.. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 1986;5:2529-2537. (Link)

Helle,M.; Brakenhoff,J.P.; De Groot,E.R.; Aarden,L.A.. Interleukin 6 is involved in interleukin 1-induced activities. Eur.J.Immunol. 1988;18:957-959. (Link)

Pettersson,T.; Metsarinne,K.; Teppo,A.M.; Fyhrquist,F.. Immunoreactive interleukin-6 in serum of patients with B-lymphoproliferative diseases. J.Intern.Med. 1992;232:439-442. (Link)

Hirano,T.; Yasukawa,K.; Harada,H.; Taga,T.; Watanabe,Y.; Matsuda,T.; Kashiwamura,S.; Nakajima,K.; Koyama,K.; Iwamatsu,A.; .. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986;324:73-76. (Link)

Ray,A.; Tatter,S.B.; Santhanam,U.; Helfgott,D.C.; May,L.T.; Sehgal,P.B.. Regulation of expression of interleukin-6. Molecular and clinical studies. Ann.N Y.Acad.Sci. 1989;557:353-361. (Link)

May,L.T.; Ghrayeb,J.; Santhanam,U.; Tatter,S.B.; Sthoeger,Z.; Helfgott,D.C.; Chiorazzi,N.; Grieninger,G.; Sehgal,P.B.. Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J.Biol.Chem. 1988;263:7760-7766. (Link)

Hirano,T.; Taga,T.; Nakano,N.; Yasukawa,K.; Kashiwamura,S.; Shimizu,K.; Nakajima,K.; Pyun,K.H.; Kishimoto,T.. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc.Natl.Acad.Sci.U S A 1985;82:5490-5494. (Link)

Oka,Y.; Murata,A.; Nishijima,J.; Yasuda,T.; Hiraoka,N.; Ohmachi,Y.; Kitagawa,K.; Yasuda,T.; Toda,H.; Tanaka,N.; .. Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 1992;4:298-304. (Link)

Horii,Y.; Iwano,M.; Hirata,E.; Shiiki,M.; Fujii,Y.; Dohi,K.; Ishikawa,H.. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int.Suppl 1993;39:S71-S75. (Link)

Ray,A.; Tatter,S.B.; Santhanam,U.; Helfgott,D.C.; May,L.T.; Sehgal,P.B.. Regulation of expression of interleukin-6. Molecular and clinical studies. Ann.N.Y.Acad.Sci. 1989;557:353-361. (Link)

Hirano,T.; Akira,S.; Taga,T.; Kishimoto,T.. Biological and clinical aspects of interleukin 6. Immunol.Today 1990;11:443-449. (Link)

Elder,J.T.; Sartor,C.I.; Boman,D.K.; Benrazavi,S.; Fisher,G.J.; Pittelkow,M.R.. Interleukin-6 in psoriasis: expression and mitogenicity studies. Arch.Dermatol.Res. 1992;284:324-332. (Link)

Merico,F.; Bergui,L.; Gregoretti,M.G.; Ghia,P.; Aimo,G.; Lindley,I.J.; Caligaris-Cappio,F.. Cytokines involved in the progression of multiple myeloma. Clin.Exp.Immunol. 1993;92:27-31. (Link)

Seguchi,T.; Yokokawa,K.; Sugao,H.; Nakano,E.; Sonoda,T.; Okuyama,A.. Interleukin-6 activity in urine and serum in patients with bladder carcinoma. J.Urol. 1992;148:791-794. (Link)

Hirano,T.; Taga,T.; Yasukawa,K.; Nakajima,K.; Nakano,N.; Takatsuki,F.; Shimizu,M.; Murashima,A.; Tsunasawa,S.; Sakiyama,F.; .. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc.Natl.Acad.Sci.U.S.A 1987;84:228-231. (Link)